These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 11032750)

  • 1. Cytotoxic activity of recombinant bFGF-rViscumin fusion proteins.
    Schmidt A; Möckel B; Eck J; Langer M; Gauert M; Zinke H
    Biochem Biophys Res Commun; 2000 Oct; 277(2):499-506. PubMed ID: 11032750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of the interchain interaction domain of chain a in viscumin cytotoxicity].
    Tonevitskiĭ AG; Agapov II; Maliuchenko NV; Moĭsenovich MM; Vediakov AM
    Mol Biol (Mosk); 2002; 36(4):672-8. PubMed ID: 12173472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preferential binding of the anticancer drug rViscumin (recombinant mistletoe lectin) to terminally alpha2-6-sialylated neolacto-series gangliosides.
    Müthing J; Burg M; Möckel B; Langer M; Metelmann-Strupat W; Werner A; Neumann U; Peter-Katalinic J; Eck J
    Glycobiology; 2002 Aug; 12(8):485-97. PubMed ID: 12145189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticancer activity of rViscumin (recombinant mistletoe lectin) in tumor colonization models with immunocompetent mice.
    Schaffrath B; Mengs U; Schwarz T; Hilgers RD; Beuth J; Möckel B; Lentzen H; Gerstmayer B
    Anticancer Res; 2001; 21(6A):3981-7. PubMed ID: 11911280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wortmannin, a phosphoinositide 3-kinase inhibitor, selectively enhances cytotoxicity of receptor-directed-toxin chimeras in vitro and in vivo.
    Davol PA; Bizuneh A; Frackelton AR
    Anticancer Res; 1999; 19(3A):1705-13. PubMed ID: 10470104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of charge variants of rViscumin by two-dimensional gel electrophoresis and mass spectrometry.
    Lutter P; Meyer HE; Langer M; Witthohn K; Dormeyer W; Sickmann A; Blüggel M
    Electrophoresis; 2001 Aug; 22(14):2888-97. PubMed ID: 11565784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of recombinant and plant-derived mistletoe lectin and their B-chains.
    Eck J; Langer M; Möckel B; Witthohn K; Zinke H; Lentzen H
    Eur J Biochem; 1999 Oct; 265(2):788-97. PubMed ID: 10504411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site-specific mutagenesis of mistletoe lectin: the role of RIP activity in apoptosis.
    Langer M; Möckel B; Eck J; Zinke H; Lentzen H
    Biochem Biophys Res Commun; 1999 Nov; 264(3):944-8. PubMed ID: 10544035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A nonradioactive assay for ribosome-inactivating proteins.
    Langer M; Rothe M; Eck J; Möckel B; Zinke H
    Anal Biochem; 1996 Dec; 243(1):150-3. PubMed ID: 8954537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mitotoxin, basic fibroblast growth factor-saporin, effectively targets human prostatic carcinoma in an animal model.
    Davol P; Frackelton AR
    J Urol; 1996 Sep; 156(3):1174-9. PubMed ID: 8709341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of mistletoe lectins and cytokines induced by them on cell proliferation of human melanoma cells in vitro.
    Thies A; Nugel D; Pfüller U; Moll I; Schumacher U
    Toxicology; 2005 Feb; 207(1):105-16. PubMed ID: 15590126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxicity of the novel anti-cancer drug rViscumin depends on HER-2 levels in SKOV-3 cells.
    Abuharbeid S; Apel J; Sander M; Fiedler B; Langer M; Zuzarte ML; Czubayko F; Aigner A
    Biochem Biophys Res Commun; 2004 Aug; 321(2):403-12. PubMed ID: 15358191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monomer/dimer equilibrium of the AB-type lectin from mistletoe enables combination of toxin/agglutinin activities in one protein: analysis of native and citraconylated proteins by ultracentrifugation/gel filtration and cell biological consequences of dimer destabilization.
    Jiménez M; Sáiz JL; André S; Gabius HJ; Solís D
    Glycobiology; 2005 Dec; 15(12):1386-95. PubMed ID: 16037489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cytotoxic type-2 ribosome inactivating protein (from leafless mistletoe) lacking sugar binding activity.
    Das MK; Sharma RS; Mishra V
    Int J Biol Macromol; 2011 Dec; 49(5):1096-103. PubMed ID: 21930153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction and characterization of a novel superantigen fusion protein: bFGF/SEB.
    Wang L; Zhang H; Zhang S; Yu M; Yang X
    Cancer Invest; 2009 May; 27(4):376-83. PubMed ID: 19160106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mistletoe lectin I is a sialic acid-specific lectin with strict preference to gangliosides and glycoproteins with terminal Neu5Ac alpha 2-6Gal beta 1-4GlcNAc residues.
    Müthing J; Meisen I; Bulau P; Langer M; Witthohn K; Lentzen H; Neumann U; Peter-Katalinić J
    Biochemistry; 2004 Mar; 43(11):2996-3007. PubMed ID: 15023051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lectin-related use of mistletoe: an experimental form of treatment with preclinically demonstrated potential risks].
    Gabius S; Gabius HJ
    Dtsch Med Wochenschr; 2002 Mar; 127(9):457-9. PubMed ID: 11870561
    [No Abstract]   [Full Text] [Related]  

  • 18. [Obtaining and characterization of the B-chains of mistletoe toxic lectins].
    Sudarkina OIu; Kurmanova AG; Kozlov IuV
    Mol Biol (Mosk); 2007; 41(4):666-73. PubMed ID: 17936987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mistletoe extracts standardized to mistletoe lectins in oncology: review on current status of preclinical research.
    Mengs U; Göthel D; Leng-Peschlow E
    Anticancer Res; 2002; 22(3):1399-407. PubMed ID: 12168816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between internalization kinetics and cytotoxicity of mistletoe lectin I to L1210 leukaemia cells.
    Walzel H; Jonas L; Rosin T; Brock J
    Folia Biol (Praha); 1990; 36(3-4):181-8. PubMed ID: 2257937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.